•  
  •  
  •  
  •  

2025-10-08 16:03:53

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss

Keywords Selected:  INE232I01014

Stock Report

  • SPARC announces submission of IND Application for SBO-154 to USFDA
  • SPARC Announces Signing of Binding Letter of Intent with UCSF and Tiller Therapeutics for Pre-clinical Oncology Asset and Associated Intellectual Property
  • SPARC announces results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson's Disease
  • SEZABY™ approved by US FDA for the treatment of neonatal seizures
  • Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US
  • SPARC to present updated clinical data of vodobatinib (SCO-088) at the 63rd ASH annual meeting
  • SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma
  • SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target

Latest Post

  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024